Intellipharmaceutics International Inc. (I.TO) reported a second-quarter net loss of $1.4 million or $0.08 per share, narrower than the net loss of $2.0 million or $0.12 per share in the comparable quarter last year.
The company attributed the narrower loss to a reduction in the fair value adjustment of derivative liability of $0.8 million and the timing of certain research and development activities.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.